Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Angiotensin receptors and β-catenin regulate brain endothelial integrity in malaria
Julio Gallego-Delgado, … , Marta Ruiz-Ortega, Ana Rodriguez
Julio Gallego-Delgado, … , Marta Ruiz-Ortega, Ana Rodriguez
Published September 19, 2016
Citation Information: J Clin Invest. 2016;126(10):4016-4029. https://doi.org/10.1172/JCI87306.
View: Text | PDF
Research Article Infectious disease Vascular biology

Angiotensin receptors and β-catenin regulate brain endothelial integrity in malaria

  • Text
  • PDF
Abstract

Cerebral malaria is characterized by cytoadhesion of Plasmodium falciparum–infected red blood cells (Pf-iRBCs) to endothelial cells in the brain, disruption of the blood-brain barrier, and cerebral microhemorrhages. No available antimalarial drugs specifically target the endothelial disruptions underlying this complication, which is responsible for the majority of malaria-associated deaths. Here, we have demonstrated that ruptured Pf-iRBCs induce activation of β-catenin, leading to disruption of inter–endothelial cell junctions in human brain microvascular endothelial cells (HBMECs). Inhibition of β-catenin–induced TCF/LEF transcription in the nucleus of HBMECs prevented the disruption of endothelial junctions, confirming that β-catenin is a key mediator of P. falciparum adverse effects on endothelial integrity. Blockade of the angiotensin II type 1 receptor (AT1) or stimulation of the type 2 receptor (AT2) abrogated Pf-iRBC–induced activation of β-catenin and prevented the disruption of HBMEC monolayers. In a mouse model of cerebral malaria, modulation of angiotensin II receptors produced similar effects, leading to protection against cerebral malaria, reduced cerebral hemorrhages, and increased survival. In contrast, AT2-deficient mice were more susceptible to cerebral malaria. The interrelation of the β-catenin and the angiotensin II signaling pathways opens immediate host-targeted therapeutic possibilities for cerebral malaria and other diseases in which brain endothelial integrity is compromised.

Authors

Julio Gallego-Delgado, Upal Basu-Roy, Maureen Ty, Matilde Alique, Cristina Fernandez-Arias, Alexandru Movila, Pollyanna Gomes, Ada Weinstock, Wenyue Xu, Innocent Edagha, Samuel C. Wassmer, Thomas Walther, Marta Ruiz-Ortega, Ana Rodriguez

×

Figure 5

Modulators of Ang II receptors inhibit Pf-iRBC–induced β-catenin activation, detachment, and disruption of IEJs in HBMECs.

Options: View larger image (or click on image) Download as PowerPoint
Modulators of Ang II receptors inhibit Pf-iRBC–induced β-catenin activat...
(A) HBMEC monolayers were incubated with specific antibodies against AT1 and AT2 receptors followed by a secondary antibody (right panels) or with only the secondary antibody (left panels). (B and C) As in Figure 4A, HBMEC monolayers were infected with β-catenin reporter lentivirus before incubation with iRBCs alone (40:1) or together with losartan (10–5 M) or CGP-42112A (10–5 M) for 18 hours. (B) The same microscopic field is shown for eGFP alone and merged with mCherry and nuclei. (C) Quantification of eGFP fluorescence per cell. (D–H) HBMEC monolayers were incubated with Pf-iRBCs, losartan, and CGP-42112A as in B followed (D–G) or not (H) by immunostaining for β-catenin (green) and nuclei (blue). (E–G) Quantification of green fluorescence intensity per cell (E), green fluorescence intensity in the perinuclear and nuclear areas versus IEJs for each cell (F), and number of cells per microscopic field (G). (H) PrestoBlue determination of viable attached HBMECs. Results are representative of at least 2 independent experiments. Scale bar: 40 μm. Error bars represent ±SEM. **P < 0.01, ***P < 0.001 compared with control. Kruskal-Wallis test and pairwise comparisons using Dunn’s procedure with a Bonferroni correction for multiple comparisons.

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts